| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/06/2009 | WO2009096112A1 Tag peptide and use thereof |
| 08/06/2009 | WO2009096049A1 Differentiated cells originating in artificial pluripotent stem cells |
| 08/06/2009 | WO2009095600A2 Novel cellular growth factor of non-animal origin and applications |
| 08/06/2009 | WO2009095403A1 Expression system and uses thereof for the production of human long pentraxin 3 |
| 08/06/2009 | WO2009094752A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009094751A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2008140044A8 Method of degrading biological tissue |
| 08/06/2009 | WO2008138131A9 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 08/06/2009 | WO2008022253A8 An unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions |
| 08/06/2009 | WO2005091925A8 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 08/06/2009 | US20090199313 Non-mevalonate isoprenoid pathway |
| 08/06/2009 | US20090199312 Shade regulatory regions |
| 08/06/2009 | US20090199311 Methods and means for producing hyaluronan |
| 08/06/2009 | US20090199308 Transgenic plants with enhanced agronomic traits |
| 08/06/2009 | US20090199307 gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation; isolated DNA molecule that exhibits terminator activity comprising a nucleic acid sequence |
| 08/06/2009 | US20090199306 Fucosyl transferase gene |
| 08/06/2009 | US20090198336 Cell co-culture for hair follicle production |
| 08/06/2009 | US20090197951 Substituted Fullerene Formulations and Their Use in Ameliorating Oxidative Stress Diseases or Inhibiting Cell Death |
| 08/06/2009 | US20090197945 Method for Generating Reference Controls for Pharmacogenomic Testing |
| 08/06/2009 | US20090197939 Methods of treating skin with aromatic skin-active ingredients |
| 08/06/2009 | US20090197927 Jasmonate derivatives, pharmaceutical compositions and methods of use thereof |
| 08/06/2009 | US20090197891 Use of (4-Alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease |
| 08/06/2009 | US20090197870 Pharmaceutical Compositions |
| 08/06/2009 | US20090197848 Synthetic mimics of mammalian cell surface receptors: method and compositions |
| 08/06/2009 | US20090197823 Aliskiren modulation of neurogenesis |
| 08/06/2009 | US20090197822 Compositions and Methods for the Treatment of Chronic Infections |
| 08/06/2009 | US20090197805 Insulin receptor antagonists and related compositions, uses and methods |
| 08/06/2009 | US20090197803 METHODS AND COMPOSITIONS FOR MODULATING T HELPER (Th) CELL DEVELOPMENT AND FUNCTION |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090197335 Method for improved transfer of dna into living cells by electroporation |
| 08/06/2009 | US20090197334 Methods of culturing embryonic stem cells and controlled differentiation |
| 08/06/2009 | US20090197333 Method for production of biological organic material and culture vessel |
| 08/06/2009 | US20090197331 Compositions for cryopreservation of cells |
| 08/06/2009 | US20090197330 Anti-cd20 monoclonal antibody |
| 08/06/2009 | US20090197329 Apparatus and method for separating biological particles using difference between gravity and magnetic force |
| 08/06/2009 | US20090197304 Corynephage integrase-based site-specific insertion vector system |
| 08/06/2009 | US20090197301 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/06/2009 | US20090197278 Antibodies to hADA2 |
| 08/06/2009 | US20090197273 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 08/06/2009 | US20090197271 Functional nucleic acid ligands to fluorescent proteins |
| 08/06/2009 | US20090197269 Translocation and mutant CSF1R Kinase in human leukemia |
| 08/06/2009 | US20090196927 Polypeptide Inhibitors of HSP27 Kinase and Uses Therefor |
| 08/06/2009 | US20090196901 Tissue Engineering Methods and Compositions |
| 08/06/2009 | US20090196888 Nucleic acids encoding recombinant 56 and 82 kDa antigents from gametocytes of Eimeria maxima and their uses |
| 08/06/2009 | US20090196884 Malaria Vaccines |
| 08/06/2009 | US20090196883 synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain of P. vivax; malaria vaccine |
| 08/06/2009 | US20090196882 Methods of producing antibodies to zalpha11 cytokine receptors |
| 08/06/2009 | US20090196878 Intestinal epithelial glucose sensor |
| 08/06/2009 | US20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/06/2009 | US20090196873 Methods and compositions for treating diseases targeting CDCP1 |
| 08/06/2009 | US20090196872 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 08/06/2009 | US20090196864 Insecticides that target protein kinase a (pka) |
| 08/06/2009 | US20090196860 Isolated Primate Embryonic Cells and Methods of Generating and Using Same |
| 08/06/2009 | US20090196859 Oligodendrocyte Precursor Cell Composition and Methods of Use |
| 08/06/2009 | US20090196857 Kidney-Derived Stem Cell Population, Identification and Therapeutic Use |
| 08/06/2009 | US20090196856 Method for Generating Dendritic Cells Employing Decreased Temperature |
| 08/06/2009 | US20090196854 Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery |
| 08/06/2009 | CA2714387A1 Extracellular matrix compositions |
| 08/06/2009 | CA2714010A1 Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells |
| 08/06/2009 | CA2713469A1 Methods and compositions relating to carcinoma stem cells |
| 08/06/2009 | CA2713462A1 Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity |
| 08/06/2009 | CA2712891A1 Synthetic surfaces for culturing stem cell derived cardiomyocytes |
| 08/05/2009 | EP2085781A1 Cells having a spectral signature, and methods of preparation and use thereof |
| 08/05/2009 | EP2085480A1 Use of the ocp3 mutation to regulate drought resistance in plants |
| 08/05/2009 | EP2085478A1 A long QT syndrome gene which encodes KVLQT1 and its association with minK |
| 08/05/2009 | EP2085477A1 A method for improving plant transformation efficiency by adding copper ion |
| 08/05/2009 | EP2085476A1 Method of enabling stable expression of transgene |
| 08/05/2009 | EP2085475A1 Method for production of cell strain capable of tetracycline-induced gene expression or cell strain having conditional gene knockout, and use of the cell strains |
| 08/05/2009 | EP2085472A1 D-serine dehydratase and use thereof |
| 08/05/2009 | EP2085471A2 Modified factor VIIA polypeptides |
| 08/05/2009 | EP2085468A1 DNA transfection system for the generation of infectious influenza virus |
| 08/05/2009 | EP2085096A2 Novel composition and methods for the treatment of immune related diseases |
| 08/05/2009 | EP2085054A1 Method for manufacturing a tissue-engineered construct |
| 08/05/2009 | EP2084534A2 Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata |
| 08/05/2009 | EP2084508A2 Preparation method |
| 08/05/2009 | EP2084278A1 Nucleic acid promoter sequences that control gene expression in plants |
| 08/05/2009 | EP2084269A2 Genetic ablation of the prp gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals |
| 08/05/2009 | EP2084268A2 Methods and compositions for treatment of bone defects with placental cell populations |
| 08/05/2009 | EP2084267A2 Cancer stem cell antigen vaccines and methods |
| 08/05/2009 | EP2084266A1 Cell culture system, method for the production thereof and use in preclinical testing |
| 08/05/2009 | EP2084265A2 Method for reducing protease activity in plant hydrolysate |
| 08/05/2009 | EP2084264A1 Three dimensional gum matrices for cell culture, manufacturing methods and methods of use |
| 08/05/2009 | EP2084263A2 Methods for inducing cardiomyogenesis |
| 08/05/2009 | EP2084189A2 Anti-cd20 antibodies and methods of use |
| 08/05/2009 | EP2084186A2 Antibody with protein a selectivity |
| 08/05/2009 | EP2083854A2 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours |
| 08/05/2009 | EP2083846A2 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 08/05/2009 | EP2019862A4 Pancreatic islet-like cells |
| 08/05/2009 | EP1987148A4 De-differentiation of astrocytes into neural stem cell using bmi-1 |
| 08/05/2009 | EP1758929A4 Methods for altering protein production rates |
| 08/05/2009 | EP1648994A4 Bio-artificial liver system |
| 08/05/2009 | EP1512014B1 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 08/05/2009 | EP1499735B1 Optimization of transgene expression in mammalian cells |
| 08/05/2009 | EP1442115B1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 08/05/2009 | EP1430085B1 Leukocyte inactivation module |
| 08/05/2009 | EP1407004B1 Ex-vivo priming for generating cd40-ligand specific cytotoxic t lymphocytes to treat autoimmune and allergic disease |
| 08/05/2009 | EP1373523B1 Genetic modification of plants for enhanced resistance and decreased uptake of heavy metals |
| 08/05/2009 | EP1246913B1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 08/05/2009 | EP1179086B1 Methods of identifying therapeutic compounds in a genetically defined setting |
| 08/05/2009 | EP1029054B1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |